West Pharmaceutical Services Net Profit Margin 2010-2024 | WST
Current and historical net profit margin for West Pharmaceutical Services (WST) from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. West Pharmaceutical Services net profit margin for the three months ending March 31, 2024 was .
| West Pharmaceutical Services Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2024-03-31 |
$2.93B |
$0.57B |
19.40% |
| 2023-12-31 |
$2.95B |
$0.59B |
20.10% |
| 2023-09-30 |
$2.93B |
$0.56B |
19.10% |
| 2023-06-30 |
$2.87B |
$0.52B |
18.10% |
| 2023-03-31 |
$2.88B |
$0.55B |
19.17% |
| 2022-12-31 |
$2.89B |
$0.59B |
20.33% |
| 2022-09-30 |
$2.91B |
$0.63B |
21.73% |
| 2022-06-30 |
$2.93B |
$0.69B |
23.46% |
| 2022-03-31 |
$2.88B |
$0.69B |
23.77% |
| 2021-12-31 |
$2.83B |
$0.66B |
23.37% |
| 2021-09-30 |
$2.68B |
$0.61B |
22.82% |
| 2021-06-30 |
$2.52B |
$0.52B |
20.53% |
| 2021-03-31 |
$2.33B |
$0.42B |
18.14% |
| 2020-12-31 |
$2.15B |
$0.35B |
16.07% |
| 2020-09-30 |
$2.04B |
$0.31B |
15.26% |
| 2020-06-30 |
$1.95B |
$0.29B |
14.65% |
| 2020-03-31 |
$1.89B |
$0.26B |
13.76% |
| 2019-12-31 |
$1.84B |
$0.24B |
13.09% |
| 2019-09-30 |
$1.79B |
$0.23B |
12.78% |
| 2019-06-30 |
$1.77B |
$0.23B |
12.90% |
| 2019-03-31 |
$1.75B |
$0.22B |
12.49% |
| 2018-12-31 |
$1.72B |
$0.21B |
12.05% |
| 2018-09-30 |
$1.71B |
$0.16B |
9.05% |
| 2018-06-30 |
$1.68B |
$0.15B |
9.00% |
| 2018-03-31 |
$1.63B |
$0.13B |
8.23% |
| 2017-12-31 |
$1.60B |
$0.15B |
9.44% |
| 2017-09-30 |
$1.57B |
$0.19B |
12.13% |
| 2017-06-30 |
$1.55B |
$0.18B |
11.46% |
| 2017-03-31 |
$1.54B |
$0.18B |
11.92% |
| 2016-12-31 |
$1.51B |
$0.14B |
9.54% |
| 2016-09-30 |
$1.49B |
$0.14B |
9.28% |
| 2016-06-30 |
$1.46B |
$0.10B |
7.01% |
| 2016-03-31 |
$1.43B |
$0.09B |
5.96% |
| 2015-12-31 |
$1.40B |
$0.10B |
6.85% |
| 2015-09-30 |
$1.39B |
$0.09B |
6.76% |
| 2015-06-30 |
$1.40B |
$0.12B |
8.77% |
| 2015-03-31 |
$1.41B |
$0.13B |
9.43% |
| 2014-12-31 |
$1.42B |
$0.13B |
8.93% |
| 2014-09-30 |
$1.42B |
$0.12B |
8.48% |
| 2014-06-30 |
$1.40B |
$0.12B |
8.28% |
| 2014-03-31 |
$1.38B |
$0.11B |
7.84% |
| 2013-12-31 |
$1.37B |
$0.11B |
8.25% |
| 2013-09-30 |
$1.35B |
$0.11B |
8.16% |
| 2013-06-30 |
$1.31B |
$0.10B |
7.48% |
| 2013-03-31 |
$1.29B |
$0.08B |
6.51% |
| 2012-12-31 |
$1.27B |
$0.08B |
6.39% |
| 2012-09-30 |
$1.24B |
$0.08B |
6.37% |
| 2012-06-30 |
$1.23B |
$0.08B |
6.59% |
| 2012-03-31 |
$1.21B |
$0.09B |
7.01% |
| 2011-12-31 |
$1.19B |
$0.08B |
6.38% |
| 2011-09-30 |
$1.17B |
$0.06B |
5.37% |
| 2011-06-30 |
$1.15B |
$0.06B |
5.56% |
| 2011-03-31 |
$1.13B |
$0.07B |
5.87% |
| 2010-12-31 |
$1.11B |
$0.07B |
5.97% |
| 2010-09-30 |
$1.12B |
$0.08B |
7.14% |
| 2010-06-30 |
$1.11B |
$0.08B |
7.12% |
| 2010-03-31 |
$1.09B |
$0.08B |
7.08% |
| 2009-12-31 |
$1.06B |
$0.07B |
6.82% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$26.953B |
$2.950B |
|
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
|
